Skip to content

Drug interactions

Temsirolimus + Zafirlukast

Severity: Moderate

Temsirolimus and Zafirlukast: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Temsirolimus and its active metabolite sirolimus are CYP3A4 substrates, so zafirlukast may raise exposure. This may increase mucositis, myelosuppression, hyperglycemia and hyperlipidemia.

What this interaction means in plain words

Temsirolimus and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Temsirolimus belongs to Oncology; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated temsirolimus and sirolimus metabolism by zafirlukast.

What to do

Monitor blood counts, glucose, lipids and mucosal toxicity. Consider an alternative to zafirlukast if toxicity emerges.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Temsirolimus and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Temsirolimus with Zafirlukast?

MediHelp rates the interaction as moderate. Temsirolimus and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Temsirolimus and its active metabolite sirolimus are CYP3A4 substrates, so zafirlukast may raise exposure. This may increase mucositis, myelosuppression, hyperglycemia and hyperlipidemia.

How serious is the interaction between Temsirolimus and Zafirlukast?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts, glucose, lipids and mucosal toxicity. Consider an alternative to zafirlukast if toxicity emerges.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in